Morgan Stanley Maintains Equal-Weight on Insulet, Lowers Price Target to $185
Portfolio Pulse from Benzinga Newsdesk
Morgan Stanley analyst Patrick Wood has maintained an Equal-Weight rating on Insulet (NASDAQ:PODD) and lowered the price target from $208 to $185.
September 29, 2023 | 12:30 pm
News sentiment analysis
Sort by:
Ascending
NEGATIVE IMPACT
Morgan Stanley has maintained an Equal-Weight rating on Insulet and lowered the price target from $208 to $185.
The lowering of the price target by Morgan Stanley could potentially lead to a decrease in the stock price of Insulet in the short term as it indicates a lower valuation of the company.
CONFIDENCE 90
IMPORTANCE 80
RELEVANCE 100